Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Muzza

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Clinical Endocrinology|July 27, 2004
BRAF mutations in an Italian cohort of thyroid cancersLaura Fugazzola, Deborah Mannavola, Valentina Cirello, et al.
Frontiers in Oncology|September 19, 2022
Thyroid cancer harboring <i>PTEN</i> and <i>TP53</i> mutations: A peculiar molecular and clinical case reportCarla Colombo, Gabriele Pogliaghi, Delfina Tosi, et al.
Endocrine|March 2, 2021
New genetics in congenital hypothyroidismAthanasia Stoupa, Dulanjalee Kariyawasam, Marina Muzza, et al.
International Journal of Cancer|October 27, 2009
Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissuesValentina Cirello, Michela Perrino, Carla Colombo, et al.
International Journal of Cancer|June 25, 2015
Fetal cell microchimerism in papillary thyroid cancer: A role in the outcome of the diseaseValentina Cirello, Carla Colombo, Michela Perrino, et al.
Endocrine-Related Cancer|September 7, 2006
An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinomaDaniela Cordella, Marina Muzza, Luisella Alberti, et al.
The Journal of Clinical Endocrinology and Metabolism|June 22, 2017
Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital HypothyroidismZehra Aycan, Hakan Cangul, Marina Muzza, et al.
Endocrine-Related Cancer|July 20, 2007
Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?Uberta Verga, Stefano Ferrero, Leonardo Vicentini, et al.
Endocrine-Related Cancer|February 28, 2021
The thyroid risk score (TRS) for nodules with indeterminate cytologyCarla Colombo, Marina Muzza, Gabriele Pogliaghi, et al.
Clinical Endocrinology|February 22, 2017
Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature reviewCarla Colombo, Marina Muzza, Maria Carla Proverbio, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Clinical Endocrinology|July 27, 2004
BRAF mutations in an Italian cohort of thyroid cancersLaura Fugazzola, Deborah Mannavola, Valentina Cirello, et al.
Frontiers in Oncology|September 19, 2022
Thyroid cancer harboring <i>PTEN</i> and <i>TP53</i> mutations: A peculiar molecular and clinical case reportCarla Colombo, Gabriele Pogliaghi, Delfina Tosi, et al.
Endocrine|March 2, 2021
New genetics in congenital hypothyroidismAthanasia Stoupa, Dulanjalee Kariyawasam, Marina Muzza, et al.
International Journal of Cancer|October 27, 2009
Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissuesValentina Cirello, Michela Perrino, Carla Colombo, et al.
International Journal of Cancer|June 25, 2015
Fetal cell microchimerism in papillary thyroid cancer: A role in the outcome of the diseaseValentina Cirello, Carla Colombo, Michela Perrino, et al.
Endocrine-Related Cancer|September 7, 2006
An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinomaDaniela Cordella, Marina Muzza, Luisella Alberti, et al.
The Journal of Clinical Endocrinology and Metabolism|June 22, 2017
Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital HypothyroidismZehra Aycan, Hakan Cangul, Marina Muzza, et al.
Endocrine-Related Cancer|July 20, 2007
Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?Uberta Verga, Stefano Ferrero, Leonardo Vicentini, et al.
Endocrine-Related Cancer|February 28, 2021
The thyroid risk score (TRS) for nodules with indeterminate cytologyCarla Colombo, Marina Muzza, Gabriele Pogliaghi, et al.
Clinical Endocrinology|February 22, 2017
Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature reviewCarla Colombo, Marina Muzza, Maria Carla Proverbio, et al.
Pageof 5